联系方式：400-650-8506
CNEN
产品名称 Tenilsetam - PAS 997 | CAS 997 | HR 029
产品货号 Axon 1470 CAS [86696-86-8] MF C8H10N2OSMW 182.24 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment. Preclinical studies on diabetic rats suggested that tenilsetam may be beneficial in the inhibition of diabetic retinopathy, without amelioration of pericyte loss References Certificates Categories Extra info G Munch et al. The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advance glycosylation. J. Neural. Transm. Sect. 1994, 8(3), 193-208.    TJ Roesler et al. Advanced glycation end product (AGE) inhibition as a possible pharmacotherapeutic strategy in the treatment of Alzheimer's disease. Drugs Fut. 1999, 24(4), 411.  Certificate of Analysis Material Safety Data Sheet CNS Diabetes & Metabolism AGE Endonuclease Alzheimer's disease therapeutic Chemical name 3-Thiophen-2-yl-piperazin-2-one Parent CAS No. [86696-86-8] Order Size Unit Price Stock 10 mg €65.00 In Stock
产品价格 现货询价，电话：010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Tenilsetam - PAS 997 | CAS 997 | HR 029

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1470

CAS [86696-86-8]

MF C8H10N2OS
MW 182.24

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

Tenilsetam

Description

Endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.

Preclinical studies on diabetic rats suggested that tenilsetam may be beneficial in the inhibition of diabetic retinopathy, without amelioration of pericyte loss
产品资料